Katy Bradford: Cassette approach offers compelling construction solution
Filter News
Area of Research
News Topics
- (-) Biomedical (17)
- (-) Frontier (15)
- 3-D Printing/Advanced Manufacturing (45)
- Advanced Reactors (10)
- Artificial Intelligence (33)
- Big Data (7)
- Bioenergy (23)
- Biology (22)
- Biotechnology (8)
- Buildings (15)
- Chemical Sciences (32)
- Clean Water (2)
- Climate Change (22)
- Composites (11)
- Computer Science (60)
- Coronavirus (17)
- Critical Materials (11)
- Cybersecurity (17)
- Decarbonization (20)
- Education (3)
- Element Discovery (1)
- Energy Storage (43)
- Environment (36)
- Exascale Computing (10)
- Fossil Energy (1)
- Fusion (16)
- Grid (15)
- High-Performance Computing (30)
- Isotopes (18)
- ITER (2)
- Machine Learning (13)
- Materials (59)
- Materials Science (52)
- Mercury (2)
- Microelectronics (1)
- Microscopy (16)
- Molten Salt (3)
- Nanotechnology (26)
- National Security (18)
- Net Zero (3)
- Neutron Science (51)
- Nuclear Energy (27)
- Partnerships (29)
- Physics (24)
- Polymers (12)
- Quantum Computing (10)
- Quantum Science (27)
- Renewable Energy (1)
- Security (11)
- Simulation (9)
- Space Exploration (3)
- Statistics (1)
- Summit (21)
- Sustainable Energy (30)
- Transformational Challenge Reactor (4)
- Transportation (25)
Media Contacts
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.